This page comes from Gattefossé's website. It was printed on 2013-05-19 : 03:17.
- Applications
-
- Formulation techniques
-
- Support&Learning
-
- Document Centre
- Regulation&Qualifications
-
Parenteral
Excipients that meet specific biocompatibility, safety and pharmacopoeia requirements for parenteral use.
read moreread lessExcipients for parenteral administration must conform to specific pharmacopoeia requirements and demonstrate physiological biocompatibility, pharmacokinetic and safety performance criteria.
We offer a specific grade of medium chain triglycerides (caprylic/capric triglycerides) Labrafac Lipophile WL1349, which conforms to European and United States-National Formulary Pharmacopoeia requirements for parenteral use. Its safety is supported by toxicological studies confirming its non-irritant and non-corrosive properties and by a long history of use as a vehicle in parenteral nutrition.
It has been used in oral and topical human pharmaceutical products and in veterinary injectables as an oily vehicle and it can be used in parenteral products as a carrier and in emulsions and suspensions.
